Polyplus-transfection SA, a biotechnology company that supports gene and cell therapy by supplying transfection solutions, has made available a GMP-grade transfection reagent PEIpro(R)-GMP in additional conditioning that aims to ensure additional flexibility and cost-efficiency.   Polyplus-transfection commercialized PEIpro-GMP at the end of 2018. This was the first transfection solution for the gene and cell therapy industry that is compliant with global cGMP viral vector manufacturing requir...